-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Anebulo Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2021 to 2024.
- Anebulo Pharmaceuticals, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending September 30, 2024 was -$1.69M, a 38% increase year-over-year.
- Anebulo Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$8.09M, a 16.4% increase from 2023.
- Anebulo Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$9.68M, a 78.1% decline from 2022.
- Anebulo Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$5.44M, a 11.6% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)